Business & Finance
Moderna Inc to donate COVID-19 vaccine via EU and EEA to COVAX for low and middle-income countries
17 November 2021 -

Biotechnology company Moderna Inc (Nasdaq:MRNA) announced on Tuesday that it entered into an agreement that enables European Union (EU) and European Economic Area (EEA) countries to donate doses of the purchased Moderna COVID-19 vaccine to COVAX to low income countries.

Led by France, Sweden and Norway, this EU and EEA initiative is expected to enable the donation of more than 70 million doses of Moderna vaccine in 2021, including an initial donation of 15 million doses by France and 40 million doses by Germany, in 2021.

Under the EU Vaccines Strategy, the agreement provides that donations of Moderna vaccine by EU and EEA countries to COVAX will be directed to the 92 Gavi COVAX Advance Market Commitment (AMC) low- and middle-income countries.

COVAX is a global initiative co-led by Gavi, the Vaccine Alliance (Gavi), the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO), to ensure equitable access to COVID-19 vaccines for all countries, regardless of income levels.